Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Next >>

Date	Time	Source	Headline	Symbol	Company
11/21/2019	12:35PM	Dow Jones News	Harpoon Therapeutics Shares Rise on Expanded Deal With AbbVie	NYSE:ABBV	AbbVie Inc
11/21/2019	9:45AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
11/21/2019	8:58AM	Dow Jones News	Harpoon, AbbVie Ink New, Expanded Agreements	NYSE:ABBV	AbbVie Inc
11/21/2019	8:30AM	PR Newswire (US)	AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annua...	NYSE:ABBV	AbbVie Inc
11/21/2019	7:35AM	PR Newswire (Canada)	Dragonfly Therapeutics annonce une collaboration avec AbbVie visant les maladies auto-immunes et l'oncologie	NYSE:ABBV	AbbVie Inc
11/21/2019	4:00AM	GlobeNewswire Inc.	Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting Tri...	NYSE:ABBV	AbbVie Inc
11/20/2019	9:47AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
11/20/2019	9:44AM	Dow Jones News	Dragonfly Therapeutics to Collaborate With AbbVie	NYSE:ABBV	AbbVie Inc
11/20/2019	8:00AM	PR Newswire (Canada)	Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology	NYSE:ABBV	AbbVie Inc
11/20/2019	8:00AM	PR Newswire (US)	Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology	NYSE:ABBV	AbbVie Inc
11/19/2019	9:55AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
11/18/2019	9:48AM	Dow Jones News	Form 8.3 - [Allergan plc]	NYSE:ABBV	AbbVie Inc
11/18/2019	8:00AM	PR Newswire (US)	AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes	NYSE:ABBV	AbbVie Inc
11/15/2019	9:42AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
11/14/2019	9:49AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
11/13/2019	10:23AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
11/13/2019	3:02AM	Dow Jones News	Credit Markets: AbbVie's $30 Billion Sale of Debt Draws Strong Demand -- WSJ	NYSE:ABBV	AbbVie Inc
11/12/2019	9:45PM	PR Newswire (US)	AbbVie Prices $30 Billion of Senior Unsecured Notes	NYSE:ABBV	AbbVie Inc
11/12/2019	6:39PM	Dow Jones News	AbbVie Sells $30 Billion of Bonds -- 2nd Update	NYSE:ABBV	AbbVie Inc
11/12/2019	3:34PM	Dow Jones News	AbbVie Prepares Large Bond Sale -- Update	NYSE:ABBV	AbbVie Inc
11/12/2019	1:32PM	Dow Jones News	AbbVie Prepares Large Bond Sale to Fund Allergan Purchase	NYSE:ABBV	AbbVie Inc
11/12/2019	11:15AM	PR Newswire (US)	New Positive Data for RINVOQ™ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 201...	NYSE:ABBV	AbbVie Inc
11/12/2019	10:19AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
11/11/2019	9:56AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
11/08/2019	5:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
11/08/2019	12:15PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ABBV	AbbVie Inc
11/08/2019	10:01AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
11/08/2019	9:17AM	Dow Jones News	J&J's Janssen Gets Health Canada OK for Expanded Imbruvica Use	NYSE:ABBV	AbbVie Inc
11/08/2019	8:27AM	Dow Jones News	J&J's Janssen Seeks FDA OK for Expanded Imbruvica Use	NYSE:ABBV	AbbVie Inc
11/08/2019	7:30AM	PR Newswire (US)	AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for th...	NYSE:ABBV	AbbVie Inc